Baidu
map

县域诊所,药监局不管了?

2018-03-15 羽兮 基础医师公社

千真万确,县域诊所的药品监管要另换“掌门”了!

千真万确,县域诊所的药品监管要另换“掌门”了!

近几天国务院接连而来的大动作让人应接不暇,对于基层药品流通领域来说最想知道的行业消息莫过于机构改革后,药品监管具体由谁来接手?且听下文分解。

再见、食药监局,你好、市场监督局

这些年药品监管领域的体制改革从未间断,纵观几十年来风云变幻,几乎是每5年一个新起点。今年3月13日,国务院机构改革方案(下称《方案》)提请十三届全国人大一次会议审议。据《方案》描述,将撤销国家食品药品监督管理总局,组建国家市场监督管理总局。



新组建的市场监管总局的主要职责是:负责市场综合监督管理,统一登记市场主体并建立信息公示和共享机制,组织市场监管综合执法工作,承担反垄断统一执法,规范和维护市场秩序,组织实施质量强国战略,负责工业产品质量安全、食品安全、特种设备安全监管,统一管理计量标准、检验检测、认证认可工作等。

和以往不同的是,药品监管机构只设到省一级,全国范围内的省药监局仅32个,以前的市、县级药监局将不复存在。

大变革下,基层药品安全谁来抓

其实早在2013年11月12日十八届三中全会《中共中央关于全面深化改革若干重大问题的决定》就曾明确:深化行政执法体制改革。整合执法主体,相对集中执法权,推进综合执法,着力解决权责交叉、多头执法问题,建立权责统一、权威高效的行政执法体制。

2017年2月3日国务院常务会议研究制定“十三五”国家食品药品安全规划时,克强总理明确要求:“我们市场监管工作在基层就是探索逐步向‘多帽合一’的综合执法方向迈进,而综合执法最重要的对象,就是与百姓生活息息相关的食品药品这些‘必需品’。”

果然,这一切在近期《国务院机构改革方案》中得到进一步落实,《方案》提出市场监督实行分级管理,药品经营销售行为的监管,由市县市场监督部门统一承担。

而据南方周末记者了解,之前因为编制、人员、财力等约束,多地无力单设食药监管机构,将近70%的县级政府选择了综合执法改革,将食药、工商、质监综合成一个统一的市场监管局,即“三局合一”。此次国家层面的改革正是吸收了基层综合改革的经验。对于全国大部分县域诊所来说,应该提前感受到了这个综合执法局的权威。

这次《方案》的出台,更是坐实未来县市场监督局将成为县域诊所药品监管的新晋“掌门”!当然监管人员极有可能是以前的原班人马,但机构名称已经改变,交叉职能会进行整合优化。

市场监管更严,诊所运营成本降低

可以看到,优化政府机构设置和职能配置,实现“一类事项原则上由一个部门统筹、一件事情原则上由一个部门负责”成为《方案》的基本逻辑。虽然具体内容还没出来,但可以大胆预测,这次机构改革对县域诊所将产生深远影响。

“三局合一”后诊所只需要面对一个总监管部门,符合业务“归口管理”原则,这样能够减少重复、多头管理,一定程度上减少诊所运营成本,而且利于各个细分部门各司其职,提高效率。

也有业内人士分析,机构调整后市场监督局一定会组建更为专业的队伍用于药品监管环节的监督执法,内行人干内行事,且配合其他科室打好组合拳。届时,药品流通领域的市场监管将会更严格,诊所人应早日调整心态,迎接随之而来的挑战。

至于机构改革后,县域诊所药品流通领域具体会迎来怎样的变化?我们拭目以待。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=297656, encodeId=496c29e656ca, content=是该改一改了., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Mon Mar 19 07:39:58 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297317, encodeId=618329e31700, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 18 07:49:26 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301568, encodeId=3e00130156838, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311094, encodeId=7bd8131109492, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296611, encodeId=1cd929661188, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Mar 16 03:00:16 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-19 lou.minghong

    是该改一改了.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=297656, encodeId=496c29e656ca, content=是该改一改了., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Mon Mar 19 07:39:58 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297317, encodeId=618329e31700, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 18 07:49:26 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301568, encodeId=3e00130156838, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311094, encodeId=7bd8131109492, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296611, encodeId=1cd929661188, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Mar 16 03:00:16 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-18 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=297656, encodeId=496c29e656ca, content=是该改一改了., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Mon Mar 19 07:39:58 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297317, encodeId=618329e31700, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 18 07:49:26 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301568, encodeId=3e00130156838, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311094, encodeId=7bd8131109492, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296611, encodeId=1cd929661188, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Mar 16 03:00:16 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-17 xuyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=297656, encodeId=496c29e656ca, content=是该改一改了., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Mon Mar 19 07:39:58 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297317, encodeId=618329e31700, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 18 07:49:26 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301568, encodeId=3e00130156838, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311094, encodeId=7bd8131109492, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296611, encodeId=1cd929661188, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Mar 16 03:00:16 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-17 ycmayy
  5. [GetPortalCommentsPageByObjectIdResponse(id=297656, encodeId=496c29e656ca, content=是该改一改了., beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Mon Mar 19 07:39:58 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297317, encodeId=618329e31700, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Mar 18 07:49:26 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301568, encodeId=3e00130156838, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311094, encodeId=7bd8131109492, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Mar 17 13:35:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296611, encodeId=1cd929661188, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Mar 16 03:00:16 CST 2018, time=2018-03-16, status=1, ipAttribution=)]
    2018-03-16 飛歌

    厉害了我的哥

    0

相关资讯

上海食药监局介绍药品流通监管重点

6月6日,上海市食药监局药械流通处处长郭术廷在上海医药商业行业协会和士研咨询共同主办的“2017全球医药商业创新大会”上介绍了上海市今年的药品流通监管工作重点。

美国食药监局正式批准诺华公司CAR-T疗法,系全球首例

据美国食品和药品监督管理局(FDA)官网8月30日(当地时间)消息,诺华公司的CAR-T疗法Kymriah(tisagenlecleucel)正式获批,这也成为全球首个获批的CAR-T疗法。

购药需谨慎!广东省食药监局曝光48批次不合格药品

记者从国家食药监总局官网了解到,广东省食品药品监督管理局组织对全省药品生产、经营企业和医疗机构进行了药品质量抽查检验。

食药监局击破十大食品谣言,你听信过几个?

“猪肉里有钩虫,煮不烂”“低钠盐=夺命盐”“化了又冻的雪糕有毒”……这些与食品有关的谣言看起来有图有“真相”,在网络上和朋友圈内广泛传播,让不少人胆战心惊。

食药监局更改茵栀黄口服制剂说明书 增腹泻等不良反应

近日,国家食品药品监督管理总局发布公告,决定对茵栀黄口服制剂说明书【不良反应】和【注意事项】项进行修订。在不良反应中增加了腹泻、呕吐和皮疹等不良反应报告。国家食品药品监督管理总局在公告中说明,注意事项中增加以下内容:1.鉴于茵栀黄口服制剂有葡萄糖-6-磷酸脱氢酶(G6PD)缺乏患者发生溶血的个例,目前关联性尚无法确定,有待进一步研究,建议葡萄糖-6-磷酸脱氢酶(G6PD)缺乏者谨慎使用。2.脾虚大

Baidu
map
Baidu
map
Baidu
map